AcelleRX Therapeutics Inc will finance clinical trial

AcelleRX Therapeutics Inc., a Cleveland, Ohio, based company, will finance it's first clinical trial on cardiovascular stem cell therapy. It received a $6.9 million investment. The company's main product is Stromal Derived Factor-1, which is given to patients immediately following a heart attack or heart failure. Read more here.